XZXia Zhang

Xia Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xia Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cross-talk between mitophagy pathways in pre-eclampsia and gestational diabetes mellitus: a systematic analysis of shared molecular mechanisms

    by Lidan He, Lin Lu, Xia Zhang, Xiuyan Wu, Feng Zhan, Jianbo Wu

    Mitophagy plays a crucial role in both pre-eclampsia (PE) and gestational diabetes mellitus (GDM); however, the molecular mechanisms connecting these conditions remain unclear. This study employs bioinformatics approaches to investigate shared mitophagy-related gene signatures in PE and GDM. We analyzed RNA sequencing data from PE and GDM patients to identify mitophagy-related differentially expressed genes (MRDEGs). Diagnostic models were constructed using RandomForest, LASSO and Nomogram, with validation through decision curve analysis (DCA) and calibration curves. Functional enrichment and regulatory networks involving MRDEGs, miRNAs and transcription factors (TFs) were constructed. Expression of key genes was subsequently validated in placental tissues through quantitative analysis. A total of 11 MRDEGs were identified. The LASSO model demonstrated promising diagnostic potential, achieving AUC values of 0.646 for PE and 0.721 for GDM. Eight key MRDEGs were closely associated with oxidative phosphorylation and reactive oxygen species (ROS) signaling pathways. Immune infiltration analysis revealed significant alterations in immune cell infiltration levels in both PE and GDM placental tissues, particularly manifesting as notable decreases in activated CD4 T cells and activated dendritic cells. These MRDEGs interacted with 80 TFs and 101 miRNAs in comprehensive regulatory networks. Finally, validation in placental tissues from control (n = 24) and disease groups (PE: n = 18, GDM: n = 20) confirmed significant differential expression of five key genes (MRPS5, PNPO, ARRB2, UBE2M, and PRAGC; all P < 0.01). This study highlights key MRDEGs as potential diagnostic biomarkers for PE and GDM, with their differential expression substantiated in placental tissues. Mitophagy likely contributes to disease pathogenesis through immune regulation and oxidative stress mechanisms, offering novel perspectives on potential therapeutic targets.


  • Open Access

    Misoprostol combined with artificial membrane stripping showed the best effect of induction among women with gestational diabetes mellitus: a retrospective cohort study

    by Xuemei Li, Qimei Yang, Xia Zhang, Lidan He, Jianbo Wu

    SUMMARY OBJECTIVE: The aim of this study was to explore the optimal method of induction of labor in women with gestational diabetes mellitus and its impact on delivery outcomes. METHODS: This retrospective cohort study was conducted among nulliparous women with gestational diabetes mellitus delivering at the First Affiliated Hospital of Fujian Medical University and the First People's Hospital of Yunnan Province from 2018 to 2023. Data were extracted from electronic medical records. RESULTS: A total of 600 patients who delivered met the inclusion criteria: the double-balloon group (Group B, n=198), the misoprostol vaginal insert group (Group M, n=200), and the Misoprostol combined with artificial membrane stripping group (Group MA, n=202). Group MA showed higher induction of labor success rates (93.5%) compared to Group M (86.0%) and Group B (81.5%, p=0.002). The time to labor onset was shortest in Group MA (32.5±6.5 h), followed by Group M (35.8±2.5 h) and Group B (45.8±4.5 h, p<0.001). Vaginal delivery time was also significantly shorter in Group MA (47.4±4.3 h) compared to Group M (49.1±7.4 h) and Group B (57.1±5.7 h, p0.05). CONCLUSION: The combination of misoprostol vaginal insert and artificial membrane stripping effectively enhances cervical ripening and improves vaginal delivery success in gestational diabetes mellitus patients, providing a promising strategy for labor induction.

  • Open Access

    Immune‐Related Four‐lncRNA Signature for Patients with Cervical Cancer

    by Jianfeng Zheng, Benben Cao, Xia Zhang, Zheng Niu, Jinyi Tong

    Cervical cancer (CC) is a common gynecological malignancy for which prognostic and therapeutic biomarkers are urgently needed. The signature based on immune‐related lncRNAs (IRLs) of CC has never been reported. This study is aimed at establishing an IRL signature for patients with CC. A cohort of 326 CC and 21 normal tissue samples with corresponding clinical information was included in this study. Twenty‐eight IRLs were collected according to the Pearson correlation analysis between the immune score and lncRNA expression (p < 0.01). Four IRLs (BZRAP1‐AS1, EMX2OS, ZNF667‐AS1, and CTC‐429P9.1) with the most significant prognostic values (p < 0.05) were identified which demonstrated an ability to stratify patients into the low‐risk and high‐risk groups by developing a risk score model. It was observed that patients in the low‐risk group showed longer overall survival (OS) than those in the high‐risk group in the training set, valid set, and total set. The area under the curve (AUC) of the receiver operating characteristic curve (ROC curve) for the four‐IRL signature in predicting the one‐, two‐, and three‐year survival rates was larger than 0.65. In addition, the low‐risk and high‐risk groups displayed different immune statuses in GSEA. These IRLs were also significantly correlated with immune cell infiltration. Our results showed that the IRL signature had a prognostic value for CC. Meanwhile, the specific mechanisms of the four IRLs in the development of CC were ascertained preliminarily.